Navigation Links
Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
Date:2/6/2013

LONDON, February 6, 2013 /PRNewswire/ --

Pharma stocks performed fairly well lately. However, the main concern for all the major companies was related to the patent expiry of their blockbuster drugs. Amgen Inc. (NASDAQ: AMGN) is about to lose its patent exclusivity for its cancer drug Neupogen. However, the sector is also witnessing good merger and acquisition activities, where big players are acquiring smaller companies in order to make up the losses sustained through patent expirations. Smaller biotech companies are also betting big on developing drugs for various cancers, though the prospects do not look so bright. StockCall analysts have released their latest round of technical research on Amgen and Peregrine. This free research can be accessed by signing up now at

http://www.stockcall.com/registration

Amgen Provides Optimistic Projections

Amgen recently reported positive results for the fourth quarter. Its revenue grew 11.25 percent to $4.42 billion while its adjusted net income stood at $1.40 per share, beating consensus estimate of $1.39 per share in quarterly net income. Amgen expects its FY 2013 adjusted earnings to be in the range of $6.85 and $7.15 per share, while revenue is likely to be in the range of $17.8 billion and $18.2 billion, in comparison to $17.3 billion in revenue it earned for FY2012. Thus, while the company is likely to report better results, but the rate of growth is likely to be a little muted. However, Amgen surpassed consensus estimates for the projections. Register today and read our free technical report on Amgen at

http://www.StockCall.com/AMGN020613.pdf

The company also successfully conducted phase 3 of its cancer drug Neulasta. Amgen draws a big chunk
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 CVS Health Corporation (NYSE: ... Friday, May 1, 2015, at 8:30 a.m. (EDT) with ... results. An audio webcast of the conference ... portion of the CVS Health website for all interested ... This webcast will be archived and available on the ...
(Date:4/17/2015)...  Trovagene, Inc., (NASDAQ:  TROV) a developer of ... presented at the 2015 European Lung Cancer Conference ... ℠ (PCM) platform outperformed tissue biopsy for ... mutations in metastatic lung cancer patients. The ... in Urinary Circulating Tumor DNA from Metastatic Non-Small ...
(Date:4/17/2015)... 17, 2015  Over the next five years, the marijuana ... with ArcView predicting that 14 more states will legalize recreational ... U.S. market for legal cannabis grew 74 percent in 2014 ... project the market could grow more than fourfold to $11 ... their stance on marijuana. Cannabiz Mobile Inc. (OTCBB: ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2
... RESTON, Va., June 1, 2011 Mirixa Corporation is ... signed a licensing agreement for MirixaEdge(SM), a clinical application ... including Medication Therapy Management (MTM). Family Physicians ... with One Source Pharmacy and selected it as FPG,s ...
... Reportlinker.com announces that a new market ... Global Intravenous (IV) Iron ... This report analyzes the ... in US$ Million. The report provides separate ...
Cached Medicine Technology:MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3Global Intravenous (IV) Iron Drugs Industry 2Global Intravenous (IV) Iron Drugs Industry 3Global Intravenous (IV) Iron Drugs Industry 4Global Intravenous (IV) Iron Drugs Industry 5Global Intravenous (IV) Iron Drugs Industry 6Global Intravenous (IV) Iron Drugs Industry 7
(Date:4/17/2015)... 17, 2015 ERGO-Pedic Products, LLC, which ... two new products to help a broader range of ... relief are the second most common visitors to doctors. ... designed specifically to help relieve sitting pain. Then, only ... thousands of happy customers later, we began getting questions ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital ... Carrollwood were all selected as Top Workplaces in Tampa ... County, is ranked number one for large businesses according ... conducted in partnership with an independent research firm. Florida ... that opened in October of 2012 with a vision ...
(Date:4/17/2015)... Washington, D.C. (PRWEB) April 17, 2015 ... today issued the following statement: “On Wednesday April 15th, ... bodies and adopted a resolution recognizing the Armenian Genocide, ... the memory of the one-and-a-half million innocent Armenian victims ... of Christians (IDC) extols the EU for this timely ...
(Date:4/17/2015)... April 17, 2015 Enthusiasts of gourmet cuisine ... Saturday, April 25, 2015. The event will be held in ... Food (201 Monroe Ave NW, Grand Rapids, MI 49503) and ... West Michigan area. Patrons are encouraged to savor the food ... fun. , This year’s event will feature seven chefs, including:, ...
(Date:4/17/2015)... Fla. (PRWEB) April 17, 2015 Most ... of dental restoration units are made overseas by foreign ... Additionally, domestic labs remain unregulated in more than 40 ... The National Association of Dental Laboratories has ... to raise awareness among patients about the consequences that ...
Breaking Medicine News(10 mins):Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:National Association Urges Transparency in Dental Industry 2
... patient in West Bengal was first refused treatment by ... till a human rights group intervened to unshackle him, ... hospital superintendent by the Association for the Protection of ... Bagda in North 24 Parganas district freed., ,Debnath ...
... Watch had explored the physiology// of hot flashes experienced by ... flashes are well known to most menopausal women—and to many ... tend to come on suddenly and last from one to ... to a feeling of being on fire. , ,Although ...
... for a new drug to treat women with //low sexual desire. ... to be done on the Intrinsa patch made by Procter & ... drug may induce, the Los Angeles Times reported. , ... healthy sexual appetites to women struggling with low desire., ...
... with higher air pollution levels may have an increased chance ... cleaner surroundings., ,The research done by scientists from Loma ... of the journal Environmental Health Perspectives. Their research findings suggest ... in women is more if they happen to live in ...
... Adyar Cancer Institute director Dr.V. Shanta is among this year's ... the prize for public service and her "untiring leadership of ... for the study and treatment of cancer// in India." ... also won a number of national and international awards. On ...
... may have increased risk of death if they choose ... University School of Medicine have found that in people// ... hemodialysis increases their risk of dying by 50 percent. ... journal Annals of Internal Medicine online Aug. 1, are ...
Cached Medicine News:Health News:Insight for Hot Flashes In Postmenopausal Women 2Health News:FDA Diminish Hopes On ‘Female Viagra 2Health News:FDA Diminish Hopes On ‘Female Viagra 3Health News:Air Pollution Increases Risk For Heart Disease In Women 2Health News:Magsaysay Award for Dr.Shanta from Chennai Cancer Institute 2Health News:Choice Of Treatment Increases Risk Of Death In Kidney Disease 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: